Fredun Pharma Allots 2,71,200 Equity Shares on Warrant Conversion

Fredun Pharmaceuticals Ltd has allotted 2,71,200 equity shares to non-promoter investors upon the conversion of warrants. This follows the exercise of rights by warrant holders who paid the balance consideration. The allotment was approved by the Board of Directors on September 16, 2026. The conversion ratio was adjusted due to a 1:2 bonus issue made by the company. The newly allotted shares will rank pari passu with existing equity shares.